Clinical significance of changes in peripheral blood lymphocyte subsets in patients with lung cancer
Minhua Shi
Abstract
Minhua Shi
Abstract
Objective To investigate the baseline immunological status in patients with lung cancer by analyzing the changes in peripheral blood lymphocyte subsets.Methods Lymphocyte subsets in the peripheral blood were detected by flow cytometry in 60 patients with lung cancer and 20 healthy controls.Results The lung cancer group had a lower percentages of CD3(+),CD4(+) lymphocytes,NK cell,and lower CD4(+)/CD8(+) ratio than the control group(P0.05),and had a higher percentage of CD8(+) cells than the control group(P0.05).There was no significant difference in the percentages of CD19(+) cells between the lung cancer group and the control group(P0.05).Conclusion The immunologic functions in patients with lung cancer were generally compromised in comparison with a healthy population.Detection of the variations of lymphocyte subsets in peripheral blood may be used in the monitoring of immune function for patients with lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the baseline immunological status in patients with lung cancer by analyzing the changes in peripheral blood lymphocyte subsets.Methods Lymphocyte subsets in the peripheral blood were detected by flow cytometry in 60 patients with lung cancer and 20 healthy controls.Results The lung cancer group had a lower percentages of CD3(+),CD4(+) lymphocytes,NK cell,and lower CD4(+)/CD8(+) ratio than the control group(P0.05),and had a higher percentage of CD8(+) cells than the control group(P0.05).There was no significant difference in the percentages of CD19(+) cells between the lung cancer group and the control group(P0.05).Conclusion The immunologic functions in patients with lung cancer were generally compromised in comparison with a healthy population.Detection of the variations of lymphocyte subsets in peripheral blood may be used in the monitoring of immune function for patients with lung cancer.
Key concepts: Lung cancer, Medicine, CD8, Immune system, CD19, Lymphocyte, Peripheral blood, Immunology